[HTML][HTML] Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant
Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
Research Article (New England Journal of Medicine) Effect of human rotavirus vaccine on severe diarrhea in African infants
…, NA Cunliffe, D Steele, D Witte, M Kirsten, C Louw… - Malawi Medical …, 2016 - ajol.info
Background: Rotavirus is the most common cause of severe gastroenteritis among young
children worldwide. Data are needed to assess the efficacy of the rotavirus vaccine in African …
children worldwide. Data are needed to assess the efficacy of the rotavirus vaccine in African …
[HTML][HTML] Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women
…, K Gill, A Kamali, P Kotze, C Louw… - … England Journal of …, 2016 - Mass Medical Soc
Background The incidence of human immunodeficiency virus (HIV) infection remains high
among women in sub-Saharan Africa. We evaluated the safety and efficacy of extended use of …
among women in sub-Saharan Africa. We evaluated the safety and efficacy of extended use of …
[HTML][HTML] Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
…, C Chuchottaworn, IM Sanne, C Louw… - The Lancet …, 2013 - thelancet.com
Background Recurrence of tuberculosis after treatment makes management difficult and is a
key factor for determining treatment efficacy. Two processes can cause recurrence: relapse …
key factor for determining treatment efficacy. Two processes can cause recurrence: relapse …
[HTML][HTML] HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for …
…, GJ Hofmeyr, J Justman, MP Kasaro, J Kiarie, C Louw… - The Lancet, 2019 - thelancet.com
Background Observational and laboratory studies suggest that some hormonal contraceptive
methods, particularly intramuscular depot medroxyprogesterone acetate (DMPA-IM), might …
methods, particularly intramuscular depot medroxyprogesterone acetate (DMPA-IM), might …
[HTML][HTML] Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial
…, P Bos, B Ngwira, D Witte, S Todd, C Louw… - BMC infectious …, 2012 - Springer
Background Rotaviruses are the most important cause of severe acute gastroenteritis worldwide
in children <5 years of age. The human, G1P[8] rotavirus vaccine Rotarix™ significantly …
in children <5 years of age. The human, G1P[8] rotavirus vaccine Rotarix™ significantly …
[HTML][HTML] Safety, acceptability and adherence of dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in Sub-Saharan Africa
…, LG Bekker, E Bukusi, E Hellstrӧm, P Kotze, C Louw… - PloS one, 2016 - journals.plos.org
Background This was the first microbicide trial conducted in Africa to evaluate an
antiretroviral-containing vaginal ring as an HIV prevention technology for women. Objectives The trial …
antiretroviral-containing vaginal ring as an HIV prevention technology for women. Objectives The trial …
[HTML][HTML] Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised …
Background There is a paucity of data on COVID-19 vaccines in people living with HIV-1,
who could be at increased risk of severe illness and death from COVID-19. We evaluated the …
who could be at increased risk of severe illness and death from COVID-19. We evaluated the …
[HTML][HTML] Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study
…, J Steytler, E Van der Ryst, C Craig, C Louw… - The Lancet …, 2021 - thelancet.com
Background The Ring Study, a phase 3 trial in 1959 sexually active women (randomised 2:1),
showed a favourable safety profile and a 31% HIV-1 infection risk reduction for a vaginal …
showed a favourable safety profile and a 31% HIV-1 infection risk reduction for a vaginal …
[HTML][HTML] Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
…, GH Wills, AM Crook, R Dawson, AH Diacon, CE Louw… - BMC medicine, 2018 - Springer
Background Drug-induced liver injury (DILI) is a common complication of tuberculosis
treatment. We utilised data from the REMoxTB clinical trial to describe the incidence of …
treatment. We utilised data from the REMoxTB clinical trial to describe the incidence of …